Moreover, gal3 has been found significantly upregulated in AD patients [27], surrounding the atherosclerotic plaques in relation to atherogenesis [46], and associated with other human diseases such as major kidney adverse events [47], stroke [48] and atopic dermatitis and psoriasis [49]. This evidence concerns the gene LGALS3 and Alzheimer disease.